937 related articles for article (PubMed ID: 22770539)
1. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
2. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
4. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
5. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies in myasthenia gravis].
Eymard B
Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
[TBL] [Abstract][Full Text] [Related]
8. Complete stable remission and autoantibody specificity in myasthenia gravis.
Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
[TBL] [Abstract][Full Text] [Related]
9. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
10. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
[TBL] [Abstract][Full Text] [Related]
13. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG.
Ohta K; Shigemoto K; Kubo S; Maruyama N; Abe Y; Ueda N; Ohta M
Neurology; 2004 Jun; 62(11):2132-3. PubMed ID: 15184636
[No Abstract] [Full Text] [Related]
14. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
[TBL] [Abstract][Full Text] [Related]
15. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
Konishi T
Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor antibodies in myasthenia gravis.
Kornfeld P; Nall J; Smith H; Mittag TW; Bender AN; Ambinder EP; Horowitz SH; Papatestas AE; Gross H; Genkins G
Muscle Nerve; 1981; 4(5):413-9. PubMed ID: 6974823
[TBL] [Abstract][Full Text] [Related]
17. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
Huang GZ; Lo YL
J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
[TBL] [Abstract][Full Text] [Related]
18. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
19. Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
Nakahara K; Nakane S; Nakajima M; Yamashita S; Mori T; Ando Y
J Neuroimmunol; 2017 Apr; 305():182-185. PubMed ID: 28100409
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
